Visual conceptRetatrutide 20 mg
Triple GIP / GLP-1 / glucagon receptor agonist (LY3437943)
- Strength:
- 20 mg
- Vial count:
- Unspecified
Investigational — not authorized for consumer sale in Canada.
Research information only · No sales · Not for human use

Purity Peps · Research Materials
Clear, evidence-graded profiles of studied peptide compounds — presented for education, not for sale.
Imagery: rendered visual concept, not inventory photography
Visual conceptTriple GIP / GLP-1 / glucagon receptor agonist (LY3437943)
Investigational — not authorized for consumer sale in Canada.
Visual conceptCopper(II) glycyl-L-histidyl-L-lysine tripeptide
Information only — not a sales offer.
Visual conceptResearch blend: BPC-157 + TB-500
Information only — not a sales offer.
Visual conceptBody Protection Compound-157 (gastric pentadecapeptide)
Information only — not a sales offer.
Visual conceptResearch combination: CJC + ipamorelin
Information only — not a sales offer.
Visual conceptBacteriostatic water
Information only — not a sales offer.
Visual conceptResearch blend: BPC-157 + TB-500 + KPV + GHK-Cu
Information only — not a sales offer.
Visual conceptLysine-proline-valine tripeptide
Information only — not a sales offer.
Visual conceptGamma-L-glutamyl-L-cysteinylglycine tripeptide
Information only — not a sales offer.
All other research entries are currently unavailable.
Continue to Full CatalogueEducational navigator
Visceral adipose tissue
Moderate — specific populations
Weight management
Strong for approved incretin drugs
Skincare & cosmetics
Limited — mostly topical / in vitro
Muscle biology
Limited
Appetite & weight gain
Limited / mixed
Recovery
Mostly preclinical
Metabolic health
Strong for approved drugs
Aging
Very limited